Verrica Pharmaceuticals Inc (VRCA)

08:07 AM

VRCA Assumed by HC Wainwright & Co. -- Buy Rating Announced - GuruFocus

08:07 AM

May 23, 2026

Number of shareholders of Verrica Pharmaceuticals Inc. – LSX:A41A98 - TradingView

May 23, 2026

May 22, 2026

Verrica Expands YCANTH Sales as Wart Trials Advance - MyChesCo

May 22, 2026

May 19, 2026

Verrica Pharmaceuticals Inc at TD Cowen Healthcare Conference Transcript - GuruFocus

May 19, 2026

May 19, 2026

Q1 2026 Verrica Pharmaceuticals Inc Earnings Call Transcript - GuruFocus

May 19, 2026

May 16, 2026

Earnings call transcript: Verrica Pharmaceuticals Q1 2026 shows revenue growth - Investing.com Nigeria

May 16, 2026

May 16, 2026

Verrica Pharmaceuticals Q1 earnings call highlights - MSN

May 16, 2026

May 15, 2026

VRCA Stock Price, Quote & Chart | VERRICA PHARMACEUTICALS INC (NASDAQ:VRCA) - ChartMill

May 15, 2026

May 14, 2026

Verrica Pharmaceuticals Inc. (VRCA) reports Q1 loss, tops revenue estimates - MSN

May 14, 2026

May 14, 2026

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Q1 2026 Earnings Call Transcript - Insider Monkey

May 14, 2026

May 14, 2026

Transcript: Verrica Pharmaceuticals Q1 2026 Earnings Conference Call - Sahm

May 14, 2026

May 14, 2026

Verrica Pharmaceuticals to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ - Sahm

May 14, 2026

May 14, 2026

Verrica Pharmaceuticals (VRCA) Returns To Larger Q1 Loss Challenging Bullish Profitability Narratives - Sahm

May 14, 2026

May 13, 2026

Verrica targets COVE-3 initiation by mid-2026 as Q1 dispensed YCANTH units rise 12.1% sequentially - MSN

May 13, 2026

May 13, 2026

Verrica (VRCA) Q1 2026 Earnings Transcript - AOL.com

May 13, 2026

May 13, 2026

Needham Maintains Verrica Pharmaceuticals(VRCA.US) With Hold Rating - Moomoo

May 13, 2026

May 13, 2026

symbol__ Stock Quote Price and Forecast - CNN

May 13, 2026

May 13, 2026

Verrica Pharmaceuticals Inc (VRCA) Q1 2026 Earnings Call Highlig - GuruFocus

May 13, 2026

May 13, 2026

Verrica Pharmaceuticals (VRCA) Reports Strong Q1 2026 Growth for YCANTH - GuruFocus

May 13, 2026

May 12, 2026

Verrica Pharmaceuticals Q1 2026 Earnings Call Transcript - MarketBeat

May 12, 2026

May 12, 2026

Verrica Pharmaceuticals Q1 Earnings Call Highlights - inkl

May 12, 2026

May 12, 2026

Verrica Pharmaceuticals (VRCA) Reports Strong Q1 Revenue Growth - GuruFocus

May 12, 2026

May 12, 2026

VRCA: Record Q1 growth for YCANTH, pipeline progress, and global expansion drive positive outlook - TradingView

May 12, 2026

May 12, 2026

Verrica Pharmaceuticals 1Q Rev $5.02M >VRCA - Moomoo

May 12, 2026

May 12, 2026

Verrica Pharmaceuticals (VRCA) Q1 2026: EPS Not Disclosed (Est - GuruFocus

May 12, 2026

May 12, 2026

VRCA: Record YCANTH growth, robust pipeline progress, and strong cash position highlight Q1 2026 - TradingView

May 12, 2026

May 12, 2026

Verrica Pharmaceuticals Inc. (VRCA) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

May 12, 2026

May 12, 2026

[10-Q] Verrica Pharmaceuticals Inc. Quarterly Earnings Report - Stock Titan

May 12, 2026

May 12, 2026

Verrica Pharmaceuticals (NASDAQ:VRCA) Q1 Results Beat Revenue Estimates as Pipeline Progress and Record Demand Drive Positive Momentum - ChartMill

May 12, 2026

May 12, 2026

Verrica Pharmaceuticals Reports First Quarter 2026 Financial Results - Sahm

May 12, 2026

May 12, 2026

Verrica (NASDAQ: VRCA) Q1 revenue hits $5.0M as YCANTH demand grows - Stock Titan

May 12, 2026

May 12, 2026

Earnings Call Summary | Verrica Pharmaceuticals(VRCA.US) Q1 2026 Earnings Conference - 富途牛牛

May 12, 2026

May 11, 2026

MSN Money - MSN

May 11, 2026

May 08, 2026

Verrica Pharmaceuticals Inc expected to post a loss of 38 cents a shareEarnings Preview - TradingView

May 08, 2026

May 06, 2026

Positive Phase II data on Verrica and Lytix’ ruxotemitide in BCC - The Pharma Letter

May 06, 2026

May 06, 2026

Lytix Biopharma ASA: New Phase II Study Data from Lytix Biopharma's Partner Verrica Pharmaceuticals to be Presented at SID 2026 Highlight Potential Abscopal Effects of Ruxotemitide in Basal Cell Carcinoma - Finansavisen

May 06, 2026

May 05, 2026

In 9 patients, Verrica's skin cancer drug shrank untreated tumors 67% - Stock Titan

May 05, 2026

May 05, 2026

Verrica Pharmaceuticals Announces Upcoming Presentation of - GlobeNewswire

May 05, 2026

May 05, 2026

Verrica Pharmaceuticals to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 12, 2026 - The Manila Times

May 05, 2026

May 05, 2026

Verrica schedules May 12 webcast for Q1 results and update - Stock Titan

May 05, 2026

May 05, 2026

Verrica Pharmaceuticals to Report First Quarter 2026 Financial Results and Provide a Corporate ... - Caledonian Record

May 05, 2026

May 05, 2026

Verrica Pharmaceuticals to Report First Quarter 2026 - GlobeNewswire

May 05, 2026

May 05, 2026

Verrica Pharmaceuticals Announces Upcoming Presentation of Phase 2 Data Highlighting the Potential Abscopal Effects of VP-315 in the Treatment of Basal Cell Carcinoma at the 2026 Society for Investigative Dermatology (SID) Annual Meeting - Yahoo Finance

May 05, 2026